Shu, T., Zheng, H., Jiang, K., Liu, F., Liu, H., Yao, L. L., Zhao, Y., Ma, Y., Zhang, Y., Shen, G., Ma, L. (2025). Preliminary analysis of disitamab vedotin combined therapy for HER2-expressing platinum-sensitive recurrent ovarian/peritoneal/fallopian tube cancer (Diversity study): A single-arm, multicenter phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.5564